91460 - Lynch Syndrome, MLH1 Sequencing and Deletion/Duplication
Sequencing: This test should be offered to patients with colorectal cancer who meet the Bethesda criteria established by the National Cancer Institute (NCI), and/or that their tumors display microsatellite instability (MSI) or replication error (RER) phenotype. Detection of a germline mutation in one or the mismatch repair genes helps to establish a clinical…
Not finding what you're looking for?
Showing all 1 results
Test guides (1)
Colorectal Cancer: Laboratory Support of Diagnosis and Management
This Topic Brief reviews selection and interpretation of laboratory tests useful for colorectal cancer screening, diagnosis, prognosis, treatment selection, and monitoring.